{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-026910","form_type":"8-K","ticker":"NUS","cik":"0001021561","company_name":"NU SKIN ENTERPRISES, INC.","filed_at":"2021-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.881021+00:00","generated_at":"2026-06-29T22:16:16.247029+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"Nu Skin Q2 revenue $704.1M, EPS $1.15 (+42% YoY), raises FY EPS guidance","bullets":["Revenue $704.1M (+15% YoY, +6% FX); EPS $1.15 vs $0.81 prior year (+42%).","Operating margin improved 260 bps to 12.1% on expense control and supply chain efficiency.","Sales leaders up 15% to 64,228; customers down 2% to 1.47M due to prior-year surge.","Q3 guidance: rev $700-730M, EPS $1.10-1.20; FY21 guidance raised to rev $2.81-2.87B, EPS $4.30-4.50.","President Ryan Napierski noted ageLOC Boost launch in EMEA and upcoming Beauty Focus Collagen+ and ageLOC Meta."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-026910","json":"https://secwatch.observer/filing/0001140361-21-026910.json","markdown":"https://secwatch.observer/filing/0001140361-21-026910.md","text":"https://secwatch.observer/filing/0001140361-21-026910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121026910/0001140361-21-026910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1021561/000114036121026910/brhc10027573_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T22:16:16.247029+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}